hypericin

hypericin is a lipid of Polyketides (PK) class. Hypericin is associated with abnormalities such as Dermatitis, Phototoxic, Dehydration, Photosensitization, Morphologically altered structure and Myocardial Infarction. The involved functions are known as Cell Cycle Checkpoints, Apoptosis, Acetylation, Cell Survival and Caspase Activation. Hypericin often locates in insoluble fraction, Cytoplasmic matrix, Protoplasm, Tissue membrane and Cytoplasm. The associated genes with hypericin are CDC37 gene, HSPA8 gene, RAF1 gene, cyclin H and FK228. The related lipids are Phosphatidylserines.

Cross Reference

Introduction

To understand associated biological information of hypericin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with hypericin?

hypericin is suspected in Dermatitis, Phototoxic, Photosensitization, Pneumonia, Psoriasis, Phototoxicity, Chronic infectious disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with hypericin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Neoplasms, Radiation-Induced D009381 3 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Per page 10 20 50 | Total 38

PubChem Associated disorders and diseases

What pathways are associated with hypericin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with hypericin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with hypericin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with hypericin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with hypericin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with hypericin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with hypericin

Download all related citations
Per page 10 20 50 100 | Total 1000
Authors Title Published Journal PubMed Link
pmid:
Lavie G et al. A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy. 1999 Br. J. Cancer pmid:10027308
Gulick RM et al. Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258. 1999 Ann. Intern. Med. pmid:10075619
Kleber E et al. Biochemical activities of extracts from Hypericum perforatum L. 1st Communication: inhibition of dopamine-beta-hydroxylase. 1999 Arzneimittelforschung pmid:10083977
Denke A et al. Biochemical activities of extracts from Hypericum perforatum L. 2nd Communication: inhibition of metenkephaline- and tyrosine-dimerization. 1999 Arzneimittelforschung pmid:10083978
Denke A et al. Biochemical activities of extracts from Hypericum perforatum L. 4th Communication: influence of different cultivation methods. 1999 Arzneimittelforschung pmid:10083980
Assefa Z et al. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. 1999 J. Biol. Chem. pmid:10085120
Delaey EM et al. Confluence dependent resistance to photo-activated hypericin in HeLa cells. 1999 Int. J. Oncol. pmid:10087326
English DS et al. Subcellular distributions and excited-state processes of hypericin in neurons. 1999 Photochem. Photobiol. pmid:10089821
Chi JD and Franklin M Determination of hypericin in plasma by high-performance liquid chromatography. 1999 J. Chromatogr. B Biomed. Sci. Appl. pmid:10202973
Chaloupka R et al. The effect of hypericin and hypocrellin-A on lipid membranes and membrane potential of 3T3 fibroblasts. 1999 Biochim. Biophys. Acta pmid:10209209
Bork PM et al. Hypericin as a non-antioxidant inhibitor of NF-kappa B. 1999 Planta Med. pmid:10364831
Das K et al. Photophysics of hypericin and hypocrellin A in complex with subcellular components: interactions with human serum albumin. 1999 Photochem. Photobiol. pmid:10378001
Calapai G et al. Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat. 1999 J. Pharm. Pharmacol. pmid:10454050
Franklin M et al. Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers. 1999 Biol. Psychiatry pmid:10459411
Schempp CM et al. Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steady-state administration of Hypericum perforatum extract (St. John's wort). 1999 Sep-Oct Skin Pharmacol. Appl. Skin Physiol. pmid:10461100
Weiner L et al. Targeted cross-linking of a molten globule form of acetylcholinesterase by the virucidal agent hypericin. 1999 Biochemistry pmid:10471290
Fiebich BL et al. Antibacterial activity of hyperforin from St John's wort. 1999 Lancet pmid:10475222
Kocisová E et al. Sequence specific interaction of the photoactive drug hypericin depends on the structural arrangement and the stability of the structure containing its specific 5AG3 target: a resonance Raman spectroscopy study. 1999 J. Biomol. Struct. Dyn. pmid:10496421
Tahara YR et al. The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathy. 1999 Curr. Eye Res. pmid:10520228
Kersten B et al. The application of the micronucleus test in Chinese hamster V79 cells to detect drug-induced photogenotoxicity. 1999 Mutat. Res. pmid:10521691
Kamuhabwa AR et al. In vitro transport and uptake of protohypericin and hypericin in the Caco-2 model. 1999 Int J Pharm pmid:10528085
Mirossay L et al. Hypericin-induced phototoxicity of human leukemic cell line HL-60 is potentiated by omeprazole, an inhibitor of H+K+-ATPase and 5'-(N,N-dimethyl)-amiloride, an inhibitor of Na+/H+ exchanger. 1999 Physiol Res pmid:10534017
Hudson JB et al. Bromohypericins are potent photoactive antiviral agents. 1999 Photochem. Photobiol. pmid:10568175
Chaloupka R et al. Over-expression of Bcl-2 does not protect cells from hypericin photo-induced mitochondrial membrane depolarization, but delays subsequent events in the apoptotic pathway. 1999 FEBS Lett. pmid:10622714
Delaey EM et al. Photocytotoxicity of protohypericin after photoconversion to hypericin. 1999 Planta Med. pmid:10630113
Kraus GA et al. Phenanthrenequinone antiretroviral agents. 2000 Bioorg. Med. Chem. Lett. pmid:10636231
Martens A et al. In vitro and in vivo evaluation of hypericin for photodynamic therapy of equine sarcoids. 2000 Vet. J. pmid:10640414
Kamuhabwa AR et al. Skin photosensitization with topical hypericin in hairless mice. 1999 Nov-Dec J. Photochem. Photobiol. B, Biol. pmid:10672536
Prince AM et al. Strategies for evaluation of enveloped virus inactivation in red cell concentrates using hypericin. 2000 Photochem. Photobiol. pmid:10687393
Kirakosyan A et al. Stimulation of the production of hypericins by mannan in Hypericum perforatum shoot cultures. 2000 Phytochemistry pmid:10703055
Lavie G et al. Inhibition of the CD8+ T cell-mediated cytotoxicity reaction by hypericin: potential for treatment of T cell-mediated diseases. 2000 Int. Immunol. pmid:10744649
Lee KT et al. Hypericin induces both differentiation and apoptosis in human promyelocytic leukemia HL-60 cells. 1999 Biol. Pharm. Bull. pmid:10746153
Chen B and de Witte PA Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model. 2000 Cancer Lett. pmid:10755394
Vandenbogaerde A et al. Evidence that total extract of Hypericum perforatum affects exploratory behavior and exerts anxiolytic effects in rats. 2000 Pharmacol. Biochem. Behav. pmid:10764915
Puchner MJ and Giese A Tamoxifen-resistant glioma-cell sub-populations are characterized by increased migration and proliferation. 2000 Int. J. Cancer pmid:10797257
Geng Y et al. Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. 2000 J. Immunol. pmid:10799921
Agostinis P et al. Apoptotic and anti-apoptotic signaling pathways induced by photodynamic therapy with hypericin. 2000 Adv. Enzyme Regul. pmid:10828351
Colasanti A et al. Hypericin photosensitization of tumor and metastatic cell lines of human prostate. 2000 J. Photochem. Photobiol. B, Biol. pmid:10836538
Moore LB et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10852961
Denke A et al. Biochemical activities of extracts from Hypericum perforatum L. 5th communication: dopamine-beta-hydroxylase-product quantification by HPLC and inhibition by hypericins and flavonoids. 2000 Arzneimittelforschung pmid:10858868
Kamuhabwa AR et al. Investigation of the absorption of hypericin into the skin of hairless mice. 2000 J. Pharm. Pharmacol. pmid:10864135
Obach RS Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. 2000 J. Pharmacol. Exp. Ther. pmid:10871299
Schempp CM et al. Effect of topical application of Hypericum perforatum extract (St. John's wort) on skin sensitivity to solar simulated radiation. 2000 Photodermatol Photoimmunol Photomed pmid:10885442
D'Hallewin MA et al. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. 2000 J. Urol. pmid:10893582
Chung PS et al. Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma. 2000 Laryngoscope pmid:10942132
Liu CD et al. Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo. 2000 J. Surg. Res. pmid:10945955
Schey KL et al. Photooxidation of lens alpha-crystallin by hypericin (active ingredient in St. John's Wort). 2000 Photochem. Photobiol. pmid:10946573
Kamuhabwa AR et al. Photodynamic activity of hypericin in human urinary bladder carcinoma cells. 2000 Jul-Aug Anticancer Res. pmid:10953329
Wentworth JM et al. St John's wort, a herbal antidepressant, activates the steroid X receptor. 2000 J. Endocrinol. pmid:10974665